Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction at Altitude
Status:
Withdrawn
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine if single dose administration of inhaled iloprost
will reduce pulmonary artery pressure, reduce hypoxic pulmonary vasoconstriction and improve
arterial oxygenation at rest and during exercise at high altitude.